Jeffrey Yu - 10 Sep 2026 Form 4 Insider Report for OneMedNet Corp (ONMD)

Reporting relationship: Chief Medical Officer, Director, 10%+ Owner
Issuer ticker: ONMD
Reported as of: 10 Sep 2026
Net transaction value: +$90,000
SEC form: 4
Accepted by SEC: 14 Sep 2026, 20:47:05 UTC
Prior SEC filing: 24 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Golden, Attorney-in-Fact

Key filing fact

Jeffrey Yu filed Form 4 for OneMedNet Corp (ONMD) on 14 Sep 2026.

Key facts

This page summarizes Jeffrey Yu's Form 4 filing for OneMedNet Corp (ONMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Sep 2026, 20:47.

Change

Previous filing in this sequence was filed on 24 Jun 2026.
Current net transaction value: +$90,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001991132 Primary reporting owner

Yu Jeffrey

Relationship: Chief Medical Officer, Director, 10%+ Owner
Address: 6385 OLD SHADY OAK ROAD,, SUITE 250, EDEN PRAIRIE
Signature: /s/ Robert Golden, Attorney-in-Fact
Signature date: 14 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONMD transaction

Common Stock

Purchase

Transaction value: $90,000
Shares: +142,857
Change %: +1.6%
Price: $0.6300
Shares after: 8,923,267
Date: 10 Sep 2026
Ownership: Direct
Footnotes: F1, F2

ONMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,311,970
Date: 10 Sep 2026
Ownership: By trust for children
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On September 10, 2026, the issuer entered into a subscription agreement with the reporting person for a $90,000 investment in the issuer.

Footnote F2

The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

Footnote F3

The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.